Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis
| Autor: | Masataka Torigoe, Mikako Iwakura, Kunitoshi Yamanaka, Keisuke Maeshima, Koji Ishii |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Etanercept Arthritis Rheumatoid Rheumatology Renal Dialysis Prednisone Internal medicine medicine Humans Diabetic Nephropathies Leukapheresis business.industry Remission Induction Middle Aged medicine.disease Tacrolimus Surgery Discontinuation Treatment Outcome Rheumatoid arthritis Orthopedic surgery Female Hemodialysis business medicine.drug |
| Zdroj: | Modern Rheumatology. |
| ISSN: | 1439-7609 1439-7595 |
| DOI: | 10.1007/s10165-013-0869-0 |
| Popis: | We report the case of a 44-year-old female undergoing maintenance hemodialysis in whom early-phase rheumatoid arthritis (RA) was successfully treated by leukocytapheresis (LCAP). The effects of prednisone, tacrolimus, and etanercept were limited, but LCAP was highly effective and its efficacy continued even after cessation of LCAP. Moreover, remission was maintained for 2 years after discontinuation of medication. LCAP may be an important treatment option for RA patients with end-stage renal failure who are on hemodialysis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink